+147.0%
MRNA vs FCEL
-81.7%
+228.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FCEL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -11.9% | +9.7% | -0.5% |
| 7D | -12.7% | -30.9% | +18.2% | -8.0% |
| 30D | -20.7% | -49.3% | +28.6% | -12.8% |
| 3M | +46.3% | -63.6% | +109.8% | +65.8% |
| 6M | +305.2% | -66.9% | +372.2% | +340.2% |
| YTD | +561.2% | -8.5% | +569.7% | +476.6% |
| 1Y | +772.1% | +6.5% | +765.6% | +631.0% |
| 3Y | +147.0% | -82.0% | +229.0% | +142.3% |
| All | +147.0% | -81.7% | +228.7% | +142.3% |
Cumulative growth
Daily Returns
Daily percentage return beside FCEL.
Daily Out/Under-Performance
Portfolio return minus FCEL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FCEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FCEL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling